Cancer detect test

Introducing 4D Lifetest™ - The game changer in early cancer detection

Clinical Trail Labor 126 small

The 4D Lifetest™ is an innovative and non-invasive immuno-oncological blood test, specifically designed to detect cancer at its earliest stages (I and II). This groundbreaking test utilizes a novel biomarker called DDS (DNA Damage Sensitivity) to meticulously assess DNA fragmentation in blood cells, ensuring unmatched accuracy and reliability.


The process begins with a simple blood sample taken from the patient. This sample is then subjected to a comprehensive analysis using the 4D Lifetest™ technology, where the unique biomarker DDS plays a crucial role in identifying potential cancer cells.


One of the most remarkable features of the 4D Lifetest™ is its early-stage sensitivity. This means the test has the extraordinary ability to detect cancer at its most treatable and potentially curable stage, empowering patients with early intervention options. Further, the user-friendly and streamlined workflow of the 4D Lifetest™ ensures simplicity and efficiency for healthcare professionals.


To guarantee the utmost reliability and efficacy, the 4D Lifetest™ undergoes extensive clinical validation, supported by compelling evidence from publications and patient data from renowned regions such as CH, EU, and US.


The 4D Lifetest™ stands as a transformative advancement in cancer diagnostics, providing healthcare professionals with unparalleled precision in early cancer detection. With its powerful DDS biomarker and cutting-edge technology, this test has the potential to redefine the landscape of cancer detection, empowering proactive healthcare and leading to improved patient outcomes.


4D Lifetest™ Lung Dx

4DLifetest Labor 477 small

Our flagship product, 4D Lifetest™ Lung Dx, is a groundbreaking tool that verifies lung cancer at its earliest stage, guiding effective treatment paths while reducing burdensome diagnostic cycles for patients.


Lung cancer patients face high mortality rates due to the lack of reliable diagnostic biomarkers for early detection. 4D Lifetest™ Lung Dx revolutionizes the game, providing crucial medical information to distinguish cancer patients from healthy individuals during primary diagnosis, leading to faster and more effective treatments. Moreover, it significantly minimizes invasive and repetitive diagnostic procedures for patients.


Our proven technology is CE IVD certified for the European market, with additional applications (4D Lifetest™ Breast Dx, 4D Lifetest™ Prostate Dx, 4D Lifetest™ Colon Dx) also available. As we expand our market activities, 4D Lifetest™ becomes an integral component in the diagnostic cascade for major cancer types and supports other liquid biopsy methods with its high early detection sensitivity.